E-DRUG: E-Drug: Anti-obesity drugs and heart disease

e-drug
1

E-Drug: Anti-obesity drugs and heart disease
     --------------------------------------------

     Dear E-druggers,

     The U.S. Food and Drug Administration (FDA) recently issued a health
     advisory on the possible but rare association of valvular heart disease in
     in women using the combination of fenfluramine and phentermine. The FDA
     press release appears below.

     Thanks.

     Syed Rizwanuddin Ahmad
     Division of Information Development
     United States Pharmacopeial Convention, Inc
     12601 Twinbrook Parkway
     Rockville, MD 20852, USA